SpiroChem
PrivateLast Round
VC Round
Dec 13, 2017
Total Funding Raised
$990,000
Momentum
Top 5%
of companies Caplight tracks
Company Overview
SpiroChem operates in Healthcare & Life Sciences and is based in Basel. Its latest recorded funding round was a VC Round in December 2017.
SpiroChem is a contract research organization that provides chemistry services for drug discovery and process R&D to the life science industry.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SpiroChem Comparables
Compare SpiroChem with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BioAscent | 90% | |
| Domainex Ltd | 84% | |
| GL CHEMTEC International | 83% |
For institutional investors. Book with your work email.
SpiroChem Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Dec 13, 2017 | ||||
| Grant | Mar 1, 2016 | ||||
| Convertible Debt | Sep 30, 2015 | ||||
| Grant | Jun 1, 2014 | ||||
| Seed | Jan 31, 2013 | ||||
Accelerator | May 26, 2011 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
SpiroChem Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innosuisse | Grant |
| Venture Kick | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 17, 2026
Added Kadmon Holdings, Inc. as a customer.
- Jul 17, 2026
Added Sail Biomedicines as a customer.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- attends_eventOct 7, 2026
SpiroChem is set to participate in the European Peptide Drug Summit 2026 in Germany on Oct 14th-15th '26, where Gerhard Müller, PhD, is set to present on medicinal chemistry approaches for advancing peptide hits.
- attends_eventSep 3, 2026
SpiroChem plans to participate in the 14th International Symposium on DNA-Encoded Chemical Libraries in Switzerland on Sep 10–11 '26, where its team discusses medicinal chemistry, synthetic chemistry and drug discovery.
For institutional investors. Book with your work email.
SpiroChem Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about SpiroChem's valuation, stock price, and market status.
Is SpiroChem a public or private company?
SpiroChem is a private company.
What is the current stock price of SpiroChem?
SpiroChem is a private company, so its shares have no public market price. Caplight tracks SpiroChem's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is SpiroChem worth (valuation)?
Valuation information for SpiroChem is not publicly available.
Can I buy SpiroChem stock?
SpiroChem shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was SpiroChem's last funding round?
SpiroChem's most recent funding round was VC Round on December 13, 2017.
Who are the main investors in SpiroChem?
Key investors in SpiroChem include Innosuisse, Venture Kick.
Will SpiroChem IPO soon?
No public IPO plans have been announced for SpiroChem.
How can I track SpiroChem secondary market activity?
Caplight tracks bids, offers, and trades in SpiroChem's shares on secondary markets.